BioCubaFarma has recently entered into three cooperative agreements with unnamed Chinese partners in Shanghai, marking the conclusion of the Fourth Forum on Cooperation Opportunities in the Cuba-China Biotechnological Sector, held during the China International Import Expo (CIIE).
These agreements focus on drug development and innovation, diagnostic production, and the establishment of a joint biopharmaceutical laboratory, as reported by EFE.
Cuban television highlighted two products showcased in China: Proctokinasa suppositories for hemorrhoid patients, and Palmex capsules, a nutritional antioxidant supplement designed to support prostate health. The Cuban government claims it is seeking partners to produce these for both Chinese and Cuban markets.
This collaboration occurs while Cuban pharmacies remain largely empty. In June, BioCubaFarma President Mayda Mauri Pérez acknowledged that the group is unable to supply 300 out of the 395 medications promised to the national healthcare system.
In addition to the three agreements, there is an announcement of a future joint research and development center, which would be the eleventh of its kind established in China with Cuban involvement.
Cuban state media also cited "over 30 joint projects at various stages," a figure only sourced from official channels and not independently verified.
The Cuban delegation in Shanghai was led by Óscar Pérez-Oliva Fraga, the Minister of Foreign Trade and Foreign Investment.
Diplomatic Tensions Amid Strengthening Ties
The agreements come during a period of heightened diplomatic tensions with the United States, as Cuba strengthens its bilateral relationship with China.
On November 5, Washington imposed sanctions on two Chinese companies—CEIEC and Beijing H&C Technologies—for allegedly supplying military components and equipment to Cuba's Ministry of the Revolutionary Armed Forces through intermediary Sociedad Mercantil Duna S.A.
China swiftly rebuffed these actions. Chinese Foreign Ministry Spokesperson Guo Jiakun stated that "cooperation with Cuba is open and transparent" and vowed that China "will take all necessary measures to protect its companies." The Cuban government accused Washington of attempting to "obstruct and sabotage" its cooperation with China.
Shortly thereafter, Cuban Foreign Minister Bruno Rodríguez Parrilla traveled to Beijing as a special envoy of the Communist Party and Cuban Government, marking his second visit to China in 2026. Chinese official Wang Yi assured continued support for Havana "regardless of how circumstances evolve," though no new economic commitments were announced.
Critics both within and outside of Cuba point out that previous biotechnological agreements with China have not alleviated shortages in hospitals or pharmacies.
Understanding Cuba's Biopharmaceutical Challenges
What are the recent agreements between Cuba and China about?
The recent agreements between Cuba and China involve drug development, innovation, diagnostic production, and the creation of a joint biopharmaceutical laboratory.
Why are Cuban pharmacies experiencing shortages?
Cuban pharmacies are experiencing shortages because BioCubaFarma cannot supply 300 of the 395 medications promised to the national healthcare system.
How is the US involved in the current tensions between Cuba and China?
The US imposed sanctions on two Chinese companies for allegedly supplying military components to Cuba, leading to increased diplomatic tensions.